GIandHepatology.com

Esophagus, Stomach & Upper GI · Article 116

What Does Esophagogastric Junction Outflow Obstruction Mean on Manometry?

EGJ outflow obstruction requires a structured, evidence-based clinical approach. This review summarizes the key diagnostic, management, monitoring and decision points for gastroenterology and hepatology practice.

EGJ outflow obstruction clinical reference
Related free clinical resource: Endoscopy and Diagnostic Imaging.

EGJ outflow obstruction: practical clinical approach

This page focuses on EGJ outflow obstruction with emphasis on decisions that change patient care, common pitfalls, and the current evidence base.

External guidance for EGJ outflow obstruction

Clinical takeaway: For EGJ outflow obstruction, decisions should integrate current guidelines, patient-specific risk, and the evidence summarized below.

Answer first: Esophagogastric junction outflow obstruction (EGJOO) on high-resolution manometry is no longer considered a treatment diagnosis by itself. Under Chicago Classification v4.0, a clinically relevant EGJOO pattern requires appropriate symptoms—dysphagia and/or noncardiac chest pain—plus manometric evidence of impaired EGJ relaxation in both supine and upright positions, and supportive evidence of obstruction from a timed barium esophagram and/or FLIP. Mechanical causes must be excluded before considering achalasia-type treatment.

Why the old definition overdiagnosed disease

An elevated integrated relaxation pressure can result from hiatal hernia, catheter artifact, opioid use, prior surgery, mechanical narrowing or normal variation. Many patients with an isolated EGJOO pattern improve without LES-disrupting therapy.

Chicago v4.0 demands clinical relevance

EGJOO should be considered inconclusive on manometry alone. The patient should have obstructive symptoms and manometric findings that persist in upright testing. Provocative maneuvers such as rapid drink challenge can provide additional evidence.

Exclude structural causes

Endoscopy is necessary to exclude stricture, eosinophilic esophagitis, tumor or postsurgical obstruction. Cross-sectional imaging is used selectively. Opioids can alter esophageal motor function and should be considered when interpreting the tracing.

Use complementary tests before irreversible therapy

A timed barium esophagram can show delayed emptying, and FLIP can demonstrate reduced EGJ distensibility. Concordant symptoms, manometry and supportive testing identify the group most likely to benefit from pneumatic dilation or myotomy.

Practical clinical algorithm

  1. Confirm dysphagia or noncardiac chest pain consistent with outflow obstruction.
  2. Review HRM for elevated IRP in the required positions and technical adequacy.
  3. Exclude mechanical obstruction with endoscopy and clinical context.
  4. Use timed barium esophagram and/or FLIP for supportive evidence.
  5. Review opioid exposure and prior foregut surgery.
  6. Reserve LES-disrupting therapy for patients with convincing clinically relevant obstruction.

Common mistakes to avoid

Trainee takeaway

EGJOO is a pattern that requires confirmation, not a stand-alone disease. Symptoms plus supportive evidence should precede LES-disrupting treatment.

Frequently asked questions

Can EGJOO resolve spontaneously?

Yes. Spontaneous symptom resolution is one reason current criteria are deliberately conservative.

Is FLIP mandatory?

No, but FLIP or timed barium testing provides valuable supportive evidence when manometry is equivocal.

Can opioids cause EGJOO-like patterns?

Yes. Opioids can alter EGJ relaxation and esophageal contractility and should be considered during interpretation.

Suggested free reading

Continue with these free books by Dr. Alan B. R. Thomson:

References

1. Thomson ABR. Practice Review in Gastroenterology. CAPstone Academic Publishers; 2014.

2. Thomson ABR. First Principles of Gastroenterology and Hepatology in Adults and Children. 7th ed. CAPstone Academic Publishers; 2013.

3. Gyawali CP, Carlson DA, Chen JW, et al. ACG Clinical Guidelines: Clinical Use of Esophageal Physiologic Testing. Am J Gastroenterol. 2020;115:1412-1428.

4. Yadlapati R, Kahrilas PJ, Fox MR, et al. Esophageal motility disorders on high-resolution manometry: Chicago Classification version 4.0. Neurogastroenterol Motil. 2021;33:e14058.

Educational content only. Clinical decisions should incorporate the individual patient, local resources, product labeling, and the most current applicable guideline or regulatory information.

← Back to Clinical Questions